clinical trial · NCT07328542
Ambulatory Blood Pressure Monitoring (ABPM) Study in Hypogonadal Men
Hypogonadism, MaleTestosterone Cypionate Injection 200 mg/mL
brief summary
A Phase 4, multi-center, open-label, single-arm 24-hour Ambulatory Blood Pressure Monitoring (ABPM) study of Testosterone Cypionate Injection in Hypogonadal Men to assess change in 24-hour ambulatory blood pressure from Baseline to End of Treatment
started
Feb 1, 2026
primary completion
Jun 1, 2027
completion
Aug 1, 2027
last updated
Jan 9, 2026
official title
A Multi-center, Open-label, Single-arm 24-hour Ambulatory Blood Pressure Monitoring (ABPM) Study of Testosterone Cypionate Injection in Hypogonadal Men
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol